Back to search
Xanthelasma Palpebrarum
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Xanthelasma Palpebrarum trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Xanthelasma Palpebrarum trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study is evaluating whether a topical cream containing 2% simvastatin can improve xanthelasma palpebrarum, a common condition that causes yellow cholestero…
Dear research participants: Participants will be invited to participate in a research project led by the Dermatology Prevention and Treatment Institute of Fuzh…
Xanthelasma palpebrarum (XP) is a common skin condition characterized by yellowish plaques that typically develop around the eyelids. While not harmful, these p…
This study aims to assess the long-term efficacy and safety of ultrapulse carbon dioxide (CO₂) laser excision in the treatment of eyelid tumors, including xanth…
Patients with diabetes with clinical feature of Xanthelasma will show increased Atherosclerosis. Objectives: Primary 1. To correlate xanthelasma and its seve…